TRIOFAN Antitussif Levodrop 6 mg/ml siroup 6 mg 15

7680704180012 CH-70418 R05DB27 03.01.2.

No images available

Details

GTIN
7680704180012
Pharmacode
-
Product number
7041801
CPT
-
Packaging group
150
Unit
ml
Composition
levodropropizinum 6 mg, E 218 1 mg, propylis parahydroxybenzoas 0.2 mg, saccharum 400 mg, acidum citricum monohydricum, aromatica (orange) cum ethanolum 1.39 mg, aqua purificata ad solutionem pro 1 ml.

Articles (1)

Triofan Antitussif Levodrop 6 mg/ml, sirop
Sirup
150
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
28/08/2026
Patient information leaflet
Français
28/08/2026
Patient information leaflet
Italien
28/08/2026
Professional SmPC
Allemand
28/08/2026
Professional SmPC
Français
28/08/2026
Professional SmPC
Italien
28/08/2026

Detailed composition

Substance Quantity Type Category
levodropropizinum
6.0 MG Substance Wirkstoff (Principe actif)
E 218
1.0 MG Substance HBESI
propylis parahydroxybenzoas
0.2 MG Substance HBESI
saccharum
400.0 MG Substance HBESI
acidum citricum monohydricum
- Substance HNIDK
aromatica
- Substance AROMA
ethanolum
1.39 MG Substance HBESI
aqua purificata
- Substance HNIDK

Authorization holder

Verfora SA

1752 Villars-sur-Glâne

Authorization information

Swissmedic authorization number
70418
Drug name
Triofan Antitussif Levodrop, sirop
Galenic form
SIRU
ATC Code
R05DB27
Authorization status
Z
Dispensation category
D
First authorization
12/08/2026
Authorization expiration date
11/08/2031
IT number
03.01.2.
Domain
Human medicine

Packaging details

Description (FR)
TRIOFAN Antitussif Levodrop 6 mg/ml siroup 6 mg 15
Description (DE)
TRIOFAN Antitussif Levodrop 6 mg/ml Sirup 6 mg 150
Market launch
07/09/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data